Assessing developmental delay with CanvasDx and Triplemoon
Is it autism, speech delay, or something else? Learn more about how CanvasDx and Triplemoon help diagnose and care for patients with developmental delay – while avoiding 6-12 month wait periods.
Diagnose Autism in Your Clinic with CanvasDx
No wait times. Easy to use. Revenue generating.
FDA APPROVED
1
Identify and enroll patient
Look for early signs of developmental delay or behavioral concern during routine visits. Enroll with Triplemoon for multidisciplinary review and CanvasDx recommendation.
2
Order CanvasDx Tool
And complete the provider questionnaire on the web-based tool.
3
Review CanvasDx recommendation
Your dedicated clinic success team guides you through results interpretation and assists with getting patient scheduled to discuss results.
4
Make diagnosis and order downstream therapies
See patient in clinic to discuss the results and place orders for recommended therapies. Triplemoon will continue to support patient.
5
Get Paid
Typical reimbursement for Triplemoon services using CanvasDx can be $285-650 per patient. See our billing guide for more information.
Triplemoon care team is with you every step of the way.
CanvasDx is a well established tool
18-72 mo
FDA Approved
Cleared for use from 18 to 72 months of age for development of screening.
97%
Negative Predictive Value
97% NPV and 95% PPV in a double blind, case-control clinical trial.
AAP
Endorsed Tool
Supported by the American Academy of Pediatrics as an
acceptable diagnostic aid
Your patients have questions. Now you have answers.
CanvasDx can be used to diagnose (or rule out) autism, and generate additional revenue for the practice.